Print page
Email page
Download PDF
« Previous Release | Next Release »
HAYWARD, Calif., Dec 10, 2009 (BUSINESS WIRE) -- Aradigm Corporation (OTCBB:ARDM) today announced that President and Chief Executive Officer Igor Gonda, Ph.D. will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences On-line Forum on December 15, 2009 at 12:00 Noon Eastern time.
Interested parties can access a live audio webcast with slides at www.aradigm.com or www.informedinvestors.com. An archived presentation will be available on both sites for 30 days.
About Aradigm
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of cystic fibrosis, bronchiectasis, inhalation anthrax infections and smoking cessation.
More information about Aradigm can be found at www.aradigm.com.
Aradigm and the Aradigm Logo are registered trademarks of Aradigm Corporation.
SOURCE: Aradigm Corporation
Aradigm Corporation
Nancy E. Pecota, 510-265-9370
Chief Financial Officer
Copyright Business Wire 2009
